Takeda's Participation in The Global Health Innovative Technology Fund

05:25 EDT 9 Apr 2013 | Takeda

The GHIT Fund is a partnership between the Government of Japan, a consortium of Japanese pharmaceutical companies (in alphabetical order: Astellas Pharma Inc.; Daiichi Sankyo Company Ltd.; Eisai Co., Ltd.; Shionogi & Co., Ltd.; Takeda), the Bill ...

Original Article: Takeda's Participation in The Global Health Innovative Technology Fund

NEXT ARTICLE

More From BioPortfolio on "Takeda's Participation in The Global Health Innovative Technology Fund"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story